Literature DB >> 5090827

Familial hyperparathyroidism.

P Marsden, J Anderson, D Doyle, B A Morris, D A Burns.   

Abstract

Twenty-eight members of a family over three generations were studied; six of them had hyperparathyroidism. Four of the six were siblings and one of these had suffered from recurrent hyperparathyroidism. No member of the family showed any other significant endocrine disturbance or active peptic ulceration.Attention is drawn to the prominent lack of symptoms despite dangerous levels of hypercalcaemia and advanced disease with the consequent need for estimation of serum calcium levels in all close relatives. Multiple gland involvement is common in familial hyperparathyroidism and is often coupled with a tendency to recurrence, necessitating long-term follow-up. Histological appearances vary considerably, and the risk of recurrence is not limited to cases showing primary chief cell hyperplasia, with the implication that resection of three parathyroid glands and part of the remaining gland may be the treatment of choice in all cases of familial hyperparathyroidism when multiple gland involvement is found.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5090827      PMCID: PMC1800132          DOI: 10.1136/bmj.3.5766.87

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  FAMILIAL HYPERPARATHYROIDISM. A KINDRED INVOLVING ELEVEN CASES, WITH A DISCUSSION OF PRIMARY CHIEF-CELL HYPERPLASIA.

Authors:  R E CUTLER; E REISS; L V ACKERMAN
Journal:  N Engl J Med       Date:  1964-04-23       Impact factor: 91.245

2.  A clinical and pathological study of 63 functioning parathyroid tumors.

Authors:  G KLEINFELD
Journal:  Cancer       Date:  1959 Sep-Oct       Impact factor: 6.860

3.  Primary chief-cell hyperplasia of the parathyroid glands: a new entity in the surgery of hyperparathyroidism.

Authors:  O COPE; W M KEYNES; S I ROTH; B CASTLEMAN
Journal:  Ann Surg       Date:  1958-09       Impact factor: 12.969

4.  Genetic aspects of adenomatosis of endocrine glands.

Authors:  P WERMER
Journal:  Am J Med       Date:  1954-03       Impact factor: 4.965

5.  Primary hyperparathyroidism; five cases in one family.

Authors:  R N FROHNER; J C WOLGAMOT
Journal:  Ann Intern Med       Date:  1954-04       Impact factor: 25.391

6.  Tumors of the parathyroid; a review of twenty-three cases.

Authors:  B K BLACK; L V ACKERMAN
Journal:  Cancer       Date:  1950-05       Impact factor: 6.860

7.  Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis.

Authors:  G J Johnson; W H Summerskill; V E Anderson; F R Keating
Journal:  N Engl J Med       Date:  1967-12-28       Impact factor: 91.245

8.  Familial hyperparathyroidism. Medical and surgical considerations.

Authors:  A L Graber; K Jacobs
Journal:  JAMA       Date:  1968-05-06       Impact factor: 56.272

9.  The differential diagnosis of parathyroid adenoma and chief cell hyperplasia.

Authors:  W C Black; J R Utley
Journal:  Am J Clin Pathol       Date:  1968-06       Impact factor: 2.493

10.  Familial hyperparathyroidism.

Authors:  N Peters; T M Chalmers; B M Truscott; J H Rack; P H Adams
Journal:  Postgrad Med J       Date:  1966-04       Impact factor: 2.401

View more
  4 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

2.  Familial hyperparathyroidism: report of a case.

Authors:  H Abe; T Tani; H Naito; E Mekata; H Sako; J Ioka; M Kodama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  New Concepts About Familial Isolated Hyperparathyroidism.

Authors:  Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2019-03-08       Impact factor: 5.958

4.  Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.

Authors:  Elena Pardi; Simona Borsari; Federica Saponaro; Fausto Bogazzi; Claudio Urbani; Stefano Mariotti; Francesca Pigliaru; Chiara Satta; Fabiana Pani; Gabriele Materazzi; Paolo Miccoli; Lorena Grantaliano; Claudio Marcocci; Filomena Cetani
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.